Abstract:CRISPR-based (Clustered regularly interspaced short palindromic repeats-based) technologies have revolutionized molecular biology and diagnostics, offering unprecedented precision and versatility. However, challenges remain, such as high costs, demanding technical expertise, and limited quantification capabilities. To overcome these limitations, innovative microfluidic platforms are emerging as powerful tools for enhancing CRISPR diagnostics. This review explores the exciting intersection of CRISPR and microfluidics, highlighting their potential to revolutionize healthcare diagnostics. By integrating CRISPR's specificity with microfluidics' miniaturization and automation, researchers are developing more sensitive and portable diagnostic tools for a range of diseases. These microfluidic devices streamline sample processing, improve diagnostic performance, and enable point-of-care applications, allowing for rapid and accurate detection of pathogens, genetic disorders, and other health conditions. The review discusses various CRISPR/Cas systems, including Cas9, Cas12, and Cas13, and their integration with microfluidic platforms. It also examines the advantages and limitations of these systems, highlighting their potential for detecting DNA and RNA biomarkers. The review also explores the key challenges in developing and implementing CRISPR-driven microfluidic diagnostics, such as ensuring robustness, minimizing cross-contamination, and achieving robust quantification. Finally, it highlights potential future directions for this rapidly evolving field, emphasizing the transformative potential of these technologies for personalized medicine and global health.

Harnessing the power of clustered regularly interspaced short palindromic repeats (CRISPR) based microfluidics for next-generation molecular diagnostics

CRISPR-Microfluidics Nexus: Advancing Biomedical Applications for Understanding and Detection

Clustered Regularly Interspaced short palindromic repeats‐Based Microfluidic System in Infectious Diseases Diagnosis: Current Status, Challenges, and Perspectives

Advances of Engineered Microfluidic Biosensors Via CRISPR/Cas in Bacteria and Virus Monitoring

Recent Progress in CRISPR-based Microfluidic Assays and Applications

Crispr-cas based biosensing: A fast-expanding molecular diagnostic tool

Advances in Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Diagnostic Assays Assisted by Micro/Nanotechnologies

Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects

Microfluidics: the propellant of CRISPR-based nucleic acid detection

Critical review on where CRISPR meets molecular diagnostics

CRISPR/Cas Biosensing Technology: From Lab Assays to Integrated Portable Devices towards Wearables

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

Challenges and perspectives of CRISPR-based technology for diagnostic applications

CRISPR-Cas-mediated Diagnostics

CRISPR-Cas Systems: Programmable Nuclease Revolutionizing the Molecular Diagnosis

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

CRISPR Cas system: A strategic approach in detection of nucleic acids

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

CRISPR: The Frontier Technology of Next-Generation RNA Detection

Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application